Calidi Biotherapeutics, Inc.
CLDIAMEX
Healthcare
Biotechnology
$0.24
-0.00(-1.6%)
52W $0.24 – $11.98
Quick:
8-K
Apr 2, 2026 (4 days ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 27, 2026 (1 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 11, 2026 (3 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 10, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Feb 10, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Feb 4, 2026 (2 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 29, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 13, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 13, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 10, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 31, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 24, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Sep 19, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 29, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Aug 27, 2025 (7 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Aug 22, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
S-1
Aug 15, 2025 (7 months ago)Registration Statement
IPO or secondary offering
Pricing, dilution, use of proceeds
8-K
Aug 14, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Aug 8, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction